Statement of the Spanish Society of Allergology and Clinical Immunology on Provocation Tests With Aspirin/Nonsteroidal Anti-inflammatory Drugs.


Journal

Journal of investigational allergology & clinical immunology
ISSN: 1018-9068
Titre abrégé: J Investig Allergol Clin Immunol
Pays: Spain
ID NLM: 9107858

Informations de publication

Date de publication:
2020
Historique:
pubmed: 19 9 2019
medline: 9 10 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used throughout the world. They are frequently involved in hypersensitivity reactions, which range from local or mild reactions to systemic and severe reactions. Consequently, it is necessary to perform an exhaustive study of patients in order to make an accurate diagnosis, search for safe procedures in the case of severe reactions, and identify alternative treatment options. Various guidelines and protocols address the management of hypersensitivity to NSAIDs, although these vary widely from country to country. The Committees of Asthma, Rhinoconjunctivitis, and Drug Allergy of the Spanish Society of Allergy and Clinical Immunology (SEAIC) propose the present position statement on available options for provocation testing with aspirin/NSAIDs. This document is the fruit of an exhaustive review of current evidence and is based on recent publications addressing the diagnosis of patients with hypersensitivity to NSAIDs and on a consensus-oriented discussion among a group of experts from the SEAIC. The main objective was to draft an easy-toread, practical guideline for health care professionals in specialist areas who assess and manage patients with suspected hypersensitivity to NSAIDs. Furthermore, indications, contraindications, and procedures for oral, bronchial, and nasal provocation tests with aspirin/NSAIDs have been updated.

Identifiants

pubmed: 31530511
doi: 10.18176/jiaci.0449
doi:

Substances chimiques

Allergens 0
Anti-Inflammatory Agents, Non-Steroidal 0
Aspirin R16CO5Y76E

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

A Izquierdo-Domínguez (A)

Allergy Service, Consorci Sanitari de Terrassa, Barcelona, Spain.
Allergy Unit, Clínica Diagonal, Barcelona, Spain.

I Bobolea (I)

Allergy Section, Servei de Pneumologia i Al.lèrgia Respiratòria, Hospital Clínic, Barcelona, Spain.

I Doña (I)

Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.

P Campo (P)

Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.

C Segura (C)

UGC Alergología, Hospital Universitario Virgen Macarena, Sevilla, Spain.

N Ortega (N)

Allergy Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.

R González (R)

Allergy Service, Hospital Universitario de Canarias, Tenerife, Spain.

J Delgado (J)

UGC Alergología, Hospital Universitario Virgen Macarena, Sevilla, Spain.

M J Torres (MJ)

Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.

M T Dordal (MT)

Allergy Unit, Servei de Medicina Interna, Hospital Universitari de Bellvitge, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH